Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease

Stopped early · Phase 4

Conditions studied: Sickle Cell Disease

In brief

The purpose of this pilot study is to provide a preliminary assessment of the feasibility and efficacy of intravenous ketamine in controlling pain in patients with sickle cell disease (who are admitted to the hospital with severe, acute pain crisis, and who have been resistant to intravenous narcotics).

Key facts

Study ID

NCT00252122

Run by

Children's Hospital of Philadelphia

People needed

3

Starts

2004-06-01

Expected to finish

2007-01-01

Last updated by the study team

2009-03-13

Who can join

Age: 7 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Children ages 7 to <19
• Acute vaso-occlusive crisis
• Persistent pain despite initial pain management with intravenous (IV) opioids

You may not qualify if…

• Contraindications to the use of ketamine
• Mental retardation or psychological conditions that may affect the proper evaluation of pain and side effects
• Known allergy to ketamine

Where it is running

• The Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.